MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FILLION, G. M. B.
Right arrow Articles by JACOB, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FILLION, G. M. B.
Right arrow Articles by JACOB, J. J.

Molecular Pharmacology, Vol 14, 50-59, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

High-Affinity Binding of [3H]5-Hydroxytryptamine to Brain Synaptosomal Membranes: Comparison with [3H]Lysergic Acid Diethylamide Binding

GILLES M. B. FILLION 1, JEAN-CLAUDE ROUSSELLE 1, MARIE-PAULE FILLION 1, DOMINIQUE M. BEAUDOIN 1, MICHAEL R. GOINY 1, JEAN-MICHEL DENIAU 1, and JOSEPH J. JACOB 1

1 Laboratory of Pharmacology, Pasteur Institute, 75724 Paris Cedex 15, France

[3H]5-Hydroxytryptamine ([3H]5-HT) binds to crude brain membrane preparations at two different sites (Kd = 1-3 nM and 10-30 nM). These two sites are present in a limited number as saturable populations and selectively bind 5-HT and related structures. In the same crude membrane preparations, lysergic acid diethylamide (LSD) also binds at two different sites (Kd = 3-4 nM and 20-30 nM). 5-HT binding is found mostly in fractions enriched in synaptosomal and microsomal membranes; fractions rich in mitochondria or in synaptic vesicles have a low binding capacity. The two serotoninergic sites are physically separable; only high-affinity binding sites are found on purified synaptosomal membranes, whereas both types of sites are present in fractions enriched in microsomal membranes. The interaction between LSD and 5-HT shows that high-affinity binding sites for 5-HT are not identical with those for LSD, since the inhibition of binding of one substance by the other is complex.

Note:
ACKNOWLEDGMENTS This investigation was supported in part by "Direction des Recherches et Moyens d'Essais (Contract No. 76/507) and Centre National de la Recherche Scientifique (A.T.P. No. 1803). We wish to thank Dr. Bocquet R., veterinaire inspecteur en chef, for his kind help in supplying horse brains.

Submitted on February 18, 1977
Accepted on September 6, 1977







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics